When considering that occurrence of postoperative late epilepsy is a cellular event before development of tumor recurrence in GBM, it will be very important to know how CD44 interacts with potential molecules participating in the seizure attack in postoperative late epilepsy. The gene discussed is CD44; the disease is epilepsy.